DKCM
PRAX icon

Davidson Kempner Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Davidson Kempner Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-667
Closed -$548K – 499
2020
Q4 		$548K Buy
+667
New +$389K 0.01% 253

Other funds holding PRAX

Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Davidson Kempner Capital Management's PRAX Position: Q1 2021 in Review

Davidson Kempner Capital Management sold out of Praxis Precision Medicines (PRAX) in Q1 2021, closing a stake of 667 shares — an estimated $548K sold.

Davidson Kempner Capital Management first reported a position in PRAX in Q4 2020 and held it in 1 quarter. The position peaked at $548K in Q4 2020. 68 funds tracked by Wall St. Rank hold PRAX as of Q1 2021.

  • Davidson Kempner Capital Management reported no remaining Praxis Precision Medicines position as of Q1 2021 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 667 Praxis Precision Medicines shares in Q1 2021, an estimated $548K.
  • Davidson Kempner Capital Management first reported a position in Praxis Precision Medicines in Q4 2020 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Praxis Precision Medicines position peaked at $548K in Q4 2020.
  • 68 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2021, filed 17 May 2021.